Replies to post #164 on Rainbow Coral Corp (fka RBCC)

[Teaks1185]

$RBCC Revenue Increased to $51,956 for the six months ended September 30, 2012 compared to $34,690 for the six months ended September 30, 2011

[Penny Roger$]

$RBCC ~ Investment Highlights

RBCC has acquired a new equity interest in Nano3D Biosciences, Inc. (n3D).
n3D's nanoparticle technology could completely revolutionize cell research.
RBCC is spearheading the most innovative scientific and medical breakthroughs in the $84.6 billion global biotech industry.
U.S. biotech companies raised $25 billion in 2010--a 15-percent jump over the previous year's investment total, according to Ernst & Young.
RBCC is joining the ranks of bioscience companies like Puma-a company that recently announced a private placement of 14.7 million shares of its common stock to investors, resulting in proceeds of $55 million.

Website: http://www.rainbowbiosciences.com/
News: http://finance.yahoo.com/q/h?s=RBCC+Headlines
Chart: http://stockcharts.com/c-sc/sc?s=RBCC&p=D&b=6&g=0&i=p06992661192&r=1357308156063

[Penny Roger$]

I hope all works out for them and that they can find some leg room in this fierce market! Market is trading nuts today.. Very easy SPY stuff happening today.

RBCC is currently in talks with a promising company based in Houston, Texas, the home of the Texas Medical Center. The undisclosed company at current holds rights to eleven patents originally issued by NASA with a range of expertise from stem cell research to cancer and back to sickle cell anemia. Once the partnership is finalized, the two companies will work together to tap into the adult stem cell research industry – a market that is expected to reach a worth of $2.4 billion by 2015.